DU Zhen, CHEN Xishan, SHENG Zengmei. Clinical value of detection of cervical thin-layer cytology test and high-risk human papilloma virus in patients with cervical cancer and cervical intraepithelial neoplasia[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 24-27. DOI: 10.7619/jcmp.202017006
Citation: DU Zhen, CHEN Xishan, SHENG Zengmei. Clinical value of detection of cervical thin-layer cytology test and high-risk human papilloma virus in patients with cervical cancer and cervical intraepithelial neoplasia[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 24-27. DOI: 10.7619/jcmp.202017006

Clinical value of detection of cervical thin-layer cytology test and high-risk human papilloma virus in patients with cervical cancer and cervical intraepithelial neoplasia

More Information
  • Received Date: June 19, 2020
  • Available Online: September 29, 2020
  • Objective To investigate the clinical value of cervical thin-layer cytology test(TCT)and high-risk human papilloma virus(hrHPV)detection in patients with cervical cancer and cervical intraepithelial neoplasia. Methods Clinical therapentic conditions of 72 cervical cancer and cervical intraepithelial neoplasia patients were retrospectively analyzed. All patients performed TCT and hrHPV. The sensitivities and specificities of TCT and hrHPV detection were analyzed, and their coincidence rates with pathological results were analyzed. Results TCT results of 72 patients showed that 42 cases presented normal results, accounting for 58.3%(42/72), and 30 cases were abnormal, accounting for 41.7%(30/72). The rate of TCT detection that was in with pathological results of cervical intraepithelial neoplasia was 44.2%(19/43), the rate of TCT detection that was in with pathological results of cervical cancer was 72.7%(8/11). The hrHPV test results showed that 52 patients were positive, accounting for 72.2%(52/72), and 20 patients were negative, accounting for 27.8%(20/72). The rate of hrHPV detection accordance with pathological results was 86.0%(37/43)in diagnosis of cervical intraepithelial neoplasia and was 90.9%(10/11)by TCT in diagnosis of cervical cancer. The sensitivity and coincidence rate of TCT and hrHPV combined detection were 94.4% and 90.3% respectively, which were significantly higher than TCT or hrHPV detection alone. Conclusion TCT - and hrHPV combined detection can improve the detection rate of patients with cervical cancer and cervical intraepithelial neoplasia.
  • 胡森阳, 唐雪. 黔江区宫颈上皮内病变妇女HPV高危亚型分布关系[J]. 中国妇幼保健, 2019, 34(20): 4633-4635.
    武丽, 李兵, 吴云涛, 等. 广东省农村妇女宫颈癌前病变及宫颈癌影响因素分析[J]. 现代预防医学, 2019, 46(19): 3509-3513.
    MANGIERI L F L, SENA M M, CEZAR-DOS-SANTOS F, et al. CCR5 genetic variants and epidemiological determinants for HPV infection and cervical premalignant lesions[J]. Int J Immunogenet, 2019, 46(5): 331-338.
    GANESAN R. HPV-related cervical glandular lesions[J]. Diagn Histopathol, 2018, 24(1): 18-25.
    BASU P, TAGHAVI K, HU S Y, et al. Management of cervical premalignant lesions[J]. Curr Probl Cancer, 2018, 42(2): 129-136.
    CASTLE P E, MUROKORA D, PEREZ C, et al. Treatment of cervical intraepithelial lesions[J]. Int J Gynecol Obstet, 2017, 138: 20-25.
    曾月, 陈梦捷, 覃露, 等. 体液免疫水平与宫颈上皮内病变及早期宫颈癌的相关性[J]. 中国免疫学杂志, 2018, 34(12): 1857-1860.
    王帆, 刘荣, 瞿全新. 宫颈随机活检在宫颈高级别病变诊断中的应用[J]. 山东医药, 2019, 59(18): 70-72.
    CANFELL K. Cervical screening in HPV-vaccinated populations[J]. Climacteric, 2018, 21(3): 227-234.
    MAGED A M, SAAD H, SALAH E, et al. Urine test for HPV genotypes as a predictor of precancerous cervical lesions and for cervical cancer screening[J]. Int J Gynecol Obstet, 2018, 141(3): 332-336.
    YALCIN I, SARI M E, SAHIN H, et al. Colposcopic biopsy findings among women with either HPV-16 only or HPV-18 only who have normal cervical cytology[J]. Int J Gynaecol Obstet, 2018, 143(3): 300-305.
    WANG, YANG Y Z, DONG W W, et al. Application of human papillomavirus in screening for cervical cancer and precancerous lesions[J]. Asian Pac J Cancer Prev, 2013,14(5): 2979-2982.
    刘双玥, 张雯, 马丽莎, 等. 宫颈高级别病变和宫颈癌患者HPV感染状况及基因型分布[J]. 江苏医药, 2019, 45(7): 653-655.
    谌琼华. HPV DNA分型检测在宫颈病变及宫颈癌鉴别诊断中的价值[J]. 检验医学, 2019, 34(6): 498-501.
    向睿, 王静依, 孟侠, 等. 不同严重程度宫颈组织学病变中宫颈HPV感染检出率及HPV和TCT在宫颈病变筛查中的价值[J]. 中国妇幼保健, 2019, 34(18): 4192-4194.
    方莉, 韩瑜, 许媛, 等. 高危型HPV感染与宫颈癌前病变及宫颈癌的相关性研究[J]. 中国实验诊断学, 2019, 23(4): 602-605.
    李洋, 李永丽, 王芦萍. HPV感染型别及多重感染对宫颈病变的影响[J]. 中华医院感染学杂志, 2019, 29(22): 3461-3464

    , 3472.
    GARLAND S M, DIMECH W, COLLIGNON P, et al. The new screening program to prevent cervical cancer using HPV DNA: getting the balance right in maintaining quality[J]. J Pathol Clin Res, 2018, 4(4): 207-212.
    NASSEREDDINE H, CHARPENTIER C, BUCAU M, et al. Interest of cytology combined with Xpert HPV and Anyplex ⅡHPV28 Detection human papillomavirus(HPV)typing: differential profiles of anal and cervical HPV lesions in HIV-infected patients on antiretroviral therapy[J]. HIV Med, 2018, 19(10): 698-707.
    由月兰, 初悦美, 荆翠红, 等. TCT、高危HPV分型检测联合阴道镜检查在宫颈癌筛查中的应用价值[J]. 中国妇幼保健, 2018, 33(2): 452-454.
    KARES S, VEIJALAINEN O, KHOLOVÁI, et al. HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?[J]. APMIS, 2019, 127(11): 710-716.
    石杏先, 余立群, 高国兰. 318例高级别宫颈上皮内瘤变及宫颈癌患者的TCT和hrHPV检测分析[J]. 中国肿瘤临床, 2019, 46(2): 73-76.
    赵培玉, 陈敖峥, 秦锦龙, 等. CervistaHR-HPVDNA检测联合TCT在宫颈癌筛查中的临床价值[J]. 检验医学, 2017, 32(4): 322-325.
    杨国红, 陆欢. HPV-DNA与TCT检测在宫颈上皮内瘤变筛查中的效果分析[J]. 中国妇幼保健, 2019, 34(23): 5406-5408.
    TIFAOUI N, MAUDELONDE T, COMBECAL J, et al. High-risk HPV detection and associated cervical lesions in a population of French menopausal women[J]. J Clin Virol, 2018, 108: 12-18.
  • Related Articles

    [1]HUANG Meimei, KANG Yun, LIU Li, DONG Qin. Application of thrombelastogram in nursing and anticoagulant therapy for patients with heart valve replacement[J]. Journal of Clinical Medicine in Practice, 2017, (12): 49-52. DOI: 10.7619/jcmp.201712015
    [2]HU Bailu, ZHANG Min, LIU Hui, RAN Xuejun. Nursing care of total hip replacement[J]. Journal of Clinical Medicine in Practice, 2017, (10): 87-90. DOI: 10.7619/jcmp.201710027
    [3]ZHAO Dongmei, MEN Lan. Effect of nursing intervention on efficacy and complication of cardiac valve replacement combined with radiofrequency catheter ablation[J]. Journal of Clinical Medicine in Practice, 2017, (10): 36-39. DOI: 10.7619/jcmp.201710012
    [4]WANG Dongyan. Clinical effect of perioperative high quality nursing intervention for patients with mitral valve replacement[J]. Journal of Clinical Medicine in Practice, 2017, (2): 1-3. DOI: 10.7619/jcmp.201702001
    [5]XU Haiyan, Zhang Yiming. Perioperative nursing of over 60 years old patients with cardiac valve replacement combined with radiofrequency ablation[J]. Journal of Clinical Medicine in Practice, 2015, (10): 20-23. DOI: 10.7619/jcmp.201510007
    [6]GAO Peibei, GU Zhengwei, WANG Lijie. Postoperative nursing for edge-to-edge repair in the treatment of mitral valve insufficiency[J]. Journal of Clinical Medicine in Practice, 2014, (14): 7-9. DOI: 10.7619/jcmp.201414003
    [7]CHEN Lingdi, MEI Ling, WU Juan, YAN Junli, BIAN Fei. Application of clinical nursing pathway in cardiac valve replacement[J]. Journal of Clinical Medicine in Practice, 2014, (6): 7-9. DOI: 10.7619/jcmp.201406003
    [8]GUO Qunfeng. Efficacy of lung protective ventilation nursingin rheumatic heart disease patients with valve replacement[J]. Journal of Clinical Medicine in Practice, 2013, (16): 153-155. DOI: 10.7619/jcmp.201316059
    [9]WANG Qiong, LIAO Lingli. Perioperative nursing and rehabilitation guidance for patients with artificial replacement of hip joint[J]. Journal of Clinical Medicine in Practice, 2013, (10): 79-81. DOI: 10.7619/jcmp.201310029
    [10]XIE Youhua, LU Hong, HUANG Chunye. Nursing experience of mechanical ventilation in patients with replacement of mitral valve[J]. Journal of Clinical Medicine in Practice, 2013, (10): 49-51. DOI: 10.7619/jcmp.201310019

Catalog

    Article views (334) PDF downloads (7) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return